跳至主要内容
临床试验/JPRN-UMIN000030108
JPRN-UMIN000030108已完成未知

Clinical study on the usefullness of edoxaban tosilate hydrate to portal vein thrombosis complicated with chronic liver disease - PVTED study

Kanazawa University Hospital0 个研究点目标入组 20 人开始时间: 2017年11月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Child-Pugh classification C. 2. Endoscopic examination confirms the presence of lesions at risk of gastrointestinal bleeding (esophageal gastric varices, gastric / duodenal ulcers, gastric antral vascular dilation, etc.), and does not perform prophylactic treatment. 3. Have active malignancy. 4. Patients taking anticoagulant or / and antiplatelet drugs. 5. Patients with a history of clear bleeding symptoms such as cerebral haemorrhage. 6. Patients who weigh less than 40 kg at registration. 7. A woman who is pregnant or has a possibility of pregnancy, within 28 days after childbirth or breast-feeding. A man who wishes to become a partner's pregnant. 8. Mental illness or psychiatric symptoms are merged and it is judged that participation in the examination is difficult. 9. It has severe hypersensitivity to the ingredients of Edoxaban. 10. Because of drug allergy, neither CT nor MRI using a contrast agent can be performed. 11. Others, the doctor in charge determines that participation in this examination is inappropriate.

研究者

相似试验

已完成
4 期
Clinical efficacy and safety of edoxaban for treatment of chronic thromboembolic pulmonary hypertensioCTEPH (chronic thromboembolic pulmonary hypertension)
JPRN-UMIN000018520Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine60
进行中(未招募)
1 期
The interaction between the blood thinner edoxaban and the hormonal treatment tamoxifen in breast cancer patientsIf there are increased plasma levels of edoxaban when used concomitantly with the P-glycoproteïne inhibitor tamoxifen for the treatment of venous thromboembolism in patients with breast cancer.
EUCTR2018-004450-24-NLTergooi Hospital, dep of internal medicine26
招募中
不适用
De wisselwerking tussen edoxaban en tamoxifen behandeling bij vrouwen met borstkankerPatients with oestrogen receptor positive breast cancer who are scheduled for adjuvant or palliative tamoxifen treatment
NL-OMON23145Daiichi Sankyo26
已完成
不适用
A pharmacokinetic study of edoxaban in patients with breast cancer using the P-glycoprotein inhibitor tamoxifevenous thromboembolism
NL-OMON49411Tergooiziekenhuizen26
已完成
不适用
A study on efficacy and safety of Edoxaban on high-risk gastrointestinal endoscopic proceduresAll diseases that require high-risk gastrointestinal endoscopic procedures such as endoscopic polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection or endoscopic mucosal ablation
JPRN-UMIN000031523iigata University Graduate School of Medical and Dental Sciences12